ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

UT System (Again) Directs DePinho to Cure MD Anderson Faculty Angst

November 7, 2014

Chabner : Opportunity To Set Own Agenda Reason For Leaving

October 28, 1994

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013